Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trialArndt Vogel, Martha M. Kirstein, Gunnar Folprecht et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 51
Nal-Iri and 5-FU/LV Compared to 5-FU/LV in Patients with Cholangio- and Gallbladder Carcinoma Previously Treated with Gemcitabine-Based Therapies: The AIO NALIRICC TrialArndt Vogel, Martha M. Kirstein, Anna Saborowski et al.|SSRN Electronic Journal|2024Cited by 0